Picture of Biophytis SA logo

ALBPS — Biophytis SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Brief: Biophytis Receives DMC Recommendation For Recruitment For Part 2 Of COVA Study

Jan 19 (Reuters) - BIOPHYTIS SA  ALBPS.PA :
    * RECEIVES DMC RECOMMENDATION FOR STARTING RECRUITMENT FOR
PART 2
OF ITS PHASE 2-3 COVA STUDY IN COVID-19
    * INDEPENDENT DATA MONITORING COMMITTEE (DMC) OF COVA STUDY
RECOMMENDS START OF RECRUITMENT OF PART 2 OF TWO-PART PHASE 2-3
STUDY
    * PATIENT RECRUITMENT FOR PART 2 OF COVA STUDY WILL START AS
SOON
AS REGULATORY/ETHICS APPROVALS OR PERMISSIONS ARE OBTAINED IN
RELEVANT JURISDICTIONS
    * INTERIM ANALYSIS ON PART 1 IS EXPECTED IN Q1 2021
    * RESULTS FROM FULL STUDY (PART 1 AND PART 2) ARE EXPECTED
IN Q2
2021, SUBJECT TO ANY COVID-19 RELATED DELAYS AND IMPACT OF
CURRENT PANDEMIC

Source text for Eikon:  ID:nGNX3DKztc 
Further company coverage:  ALBPS.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Biophytis SA

See all news